Search

Author/Creator Osburg, Lukas

1. A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL. Issue 3 (14th March 2022)

Authors:
Mehta, Naveen K; Pfluegler, Martin; Meetze, Kristan; Li, Bochong; Sindel, Isabelle; Vogt, Fabian; Marklin, Melanie; Heitmann, Jonas S; Kauer, Joseph; Osburg, Lukas; Zekri, Latifa; Bühring, Hans-Jörg; Mueller, Stefanie; Hörner, Sebastian; Baeuerle, Patrick A; Michaelson, Jennifer S; Jung, Gundram;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer. Issue 2 (29th December 2020)

Authors:
Zekri, Latifa; Vogt, Fabian; Osburg, Lukas; Müller, Stefanie; Kauer, Joseph; Manz, Timo; Pflügler, Martin; Maurer, Andreas; Heitmann, Jonas S; Hagelstein, Ilona; Märklin, Melanie; Hörner, Sebastian; Todenhöfer, Tilmann; Calaminus, Carsten; Stenzl, Arnulf; Pichler, Bernd; la Fougère, Christian; Sc...
Journal:
EMBO molecular medicine
Issue:
Volume 13:Issue 2(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies. Issue 1 (30th May 2020)

Authors:
Kauer, Joseph; Hörner, Sebastian; Osburg, Lukas; Müller, Stefanie; Märklin, Melanie; Heitmann, Jonas S; Zekri, Latifa; Rammensee, Hans-Georg; Salih, Helmut R; Jung, Gundram
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗